John Khade, MD
General Practice · Fremont
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 5
Offices
5 locations · Bay Area Community Health · 106 clinicians in this group
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Khade’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence C159495 · Current
Licensed to practise in California · since 2018 · expires 2028-11-30 · Saba University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$492,601 in 2024
Medicaid paid $492,601 for 5,483 billed services this clinician did in 2024, up to 176 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 2,086 | $487,064 |
| Short return visit | 1,935 | $2,836 |
| Short return visit (20+ min) | 1,003 | $1,855 |
| Return visit (30+ min) | 216 | $557 |
| OFF/OP EST MAY X REQ PHY/QHP | 108 | $180 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 88 | $71 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 23 | $37 |
| New patient visit (30+ min) | 24 | $0 |
| 2024 | 5,483 | 8 | 176 | $492,601 |
| 2023 | 1,934 | 5 | 126 | $185,111 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 713 | $182,765 |
| Short return visit | 439 | $936 |
| Short return visit (20+ min) | 582 | $898 |
| Return visit (30+ min) | 136 | $463 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 64 | $50 |
Drugs they prescribed that Part D paid
$110,810
Pharmacies billed $110,810 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
738 generic and 131 brand-name prescriptions · $110,810 in drug cost · 17 antibiotic prescriptions to 15 people · 11 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 16 | $24,460 | $1,529 |
| Januvia | 17 | $21,923 | $1,290 |
| Albuterol Sulfate Hfa | 24 | $1,100 | $46 |
| Oxybutynin Chloride Er | 12 | $298 | $25 |
| Atorvastatin | 72 | $279 | $4 |
See all 23 drugs
| Jardiance | 16 | $24,460 | $1,529 |
| Januvia | 17 | $21,923 | $1,290 |
| Albuterol Sulfate Hfa | 24 | $1,100 | $46 |
| Oxybutynin Chloride Er | 12 | $298 | $25 |
| Atorvastatin | 72 | $279 | $4 |
| Gabapentin | 11 | $266 | $24 |
| Levothyroxine | 37 | $254 | $7 |
| Metoprolol | 20 | $247 | $12 |
| Lisinopril | 42 | $141 | $3 |
| Hydralazine | 16 | $140 | $9 |
| Losartan | 31 | $139 | $4 |
| Tamsulosin | 20 | $134 | $7 |
| Amlodipine Besylate | 58 | $109 | $2 |
| Metformin | 26 | $107 | $4 |
| Tizanidine | 12 | $73 | $6 |
| Famotidine | 11 | $72 | $7 |
| Alendronate | 13 | $63 | $5 |
| Atenolol | 13 | $51 | $4 |
| Simvastatin | 11 | $33 | $3 |
| Furosemide | 13 | $30 | $2 |
| Ibuprofen | 12 | $29 | $2 |
| Diazepam | 12 | $28 | $2 |
| Hydrochlorothiazide | 18 | $23 | $1 |
Year by year
| 2024 | 882 | 111 | None | 15% | $110,810 |
| 2023 | 277 | 53 | None | 5% | $20,050 |
| 2018 | 66 | 29 | None | None | $1,404 |
| 2017 | 240 | 55 | None | None | $7,473 |
| 2016 | 729 | 172 | 3% (20) | None | $31,680 |
| 2015 | 457 | 138 | 6% (29) | None | $23,685 |
| 2014 | 101 | 44 | None | 26% | $6,633 |
| 2013 | 25 | None | 0% (0) | None | $2,633 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Lisinopril | 22 | $469 | $21 |
| Atorvastatin | 19 | $321 | $17 |
| Amlodipine Besylate | 12 | $223 | $19 |
2017: 3 drugs
| Atorvastatin | 17 | $165 | $10 |
| Losartan | 12 | $58 | $5 |
| Lisinopril | 15 | $50 | $3 |
2016: 21 drugs
| Atorvastatin | 31 | $463 | $15 |
| Pravastatin | 15 | $461 | $31 |
| Tamsulosin | 13 | $420 | $32 |
| Levothyroxine | 11 | $297 | $27 |
| Amlodipine Besylate | 38 | $273 | $7 |
| Triamcinolone Acetonide | 11 | $252 | $23 |
| Metoprolol | 16 | $250 | $16 |
| Metformin | 27 | $249 | $9 |
| Omeprazole | 27 | $225 | $8 |
| Gabapentin | 12 | $204 | $17 |
| Lisinopril | 34 | $158 | $5 |
| Ibuprofen | 17 | $126 | $7 |
| Carvedilol | 11 | $124 | $11 |
| Simvastatin | 13 | $111 | $9 |
| Tramadol | 16 | $98 | $6 |
| Azithromycin | 13 | $91 | $7 |
| Hydrochlorothiazide | 14 | $89 | $6 |
| Losartan | 14 | $85 | $6 |
| Furosemide | 12 | $54 | $4 |
| Ciprofloxacin | 13 | $52 | $4 |
| Meloxicam | 11 | $36 | $3 |
2015: 8 drugs
| Pravastatin | 13 | $521 | $40 |
| Gabapentin | 13 | $341 | $26 |
| Atorvastatin | 15 | $298 | $20 |
| Hydrocodone-Acetaminophen | 16 | $230 | $14 |
| Lisinopril | 22 | $144 | $7 |
| Levothyroxine | 14 | $133 | $9 |
| Lisinopril-Hydrochlorothiazide | 11 | $98 | $9 |
| Simvastatin | 11 | $78 | $7 |
Money from drug and device companies
$94 in 2025
| 2025 | 3 | 4 | None | $94 |
| 2024 | 1 | 1 | None | $21 |
| 2023 | 1 | 2 | None | $19 |
| 2019 | 4 | 4 | None | $250 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Exact Sciences | Cologuard Collection Kit | $54 | 2 payments
|
| Dynavax Technologies | Heplisav-B | $26 | 1 payment
|
| CooperSurgical | Paragard T 380a | $13 | 1 payment
|
See all 4 published payments
| Exact Sciences | Meals · 2025-11-03 | Cologuard Collection Kit | $30 |
| Exact Sciences | Meals · 2025-07-17 | Cologuard Collection Kit | $24 |
| Dynavax Technologies | Meals · 2025-07-14 | Heplisav-B | $26 |
| CooperSurgical | Meals · 2025-04-15 | Paragard T 380a | $13 |
See earlier years (2024, 2023, 2019)
2024: $21
| Sanofi Pasteur | Beyfortus | $21 | 1 payment
|
2023: $19
| Dynavax Technologies | Heplisav-B | $19 | 2 payments
|
2019: $250
| BioDelivery Sciences International | Belbuca | $73 | 1 payment
|
| Pfizer | None | $63 | 1 payment
|
| Collegium Pharmaceutical | Xtampza Er | $58 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Lucemyra | $55 | 1 payment
|
Professional record
- NPI
- 1952668063
- Licence
- CA C159495, GA 071543California C159495: Current · expires 2028-11-30
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- General practice (208D00000X)
- Mailing address
- 1803 Moreland Dr, Alameda, CA, 94501
- NPI first listed
- 2012-04-13
- NPI last updated
- 2026-09-17
- NPI record certified
- 2026-09-17
This is when the NPI record was last certified, not a medical board exam.